Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Neurokinin antagonists in early development at AstraZeneca

Feb. 15, 2000

First market introduction for INOmax

Feb. 15, 2000

Synthesis and use of new PKC inhibitors in development at AstraZeneca

Feb. 15, 2000

PPL Therapeutics' transgenic AAT shows promising results in phase II

Feb. 14, 2000

Chinese university scientists design new antiallergic medications

Feb. 10, 2000

HMR contributes novel antihistaminics to Aventis pipeline

Feb. 9, 2000

Potent cell adhesion inhibitors result from Pharmacia & Upjohn/Tanabe Seiyaku collaboration

Feb. 9, 2000

Rhinocort Aqua available across U.S. for allergy relief

Feb. 9, 2000

U.S. and Scottish scientists discover novel CCR3 antagonist that inhibits eosinophil migration

Feb. 8, 2000

Antiasthmatic agent ME-3301 in clinical trials in Europe

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...